Research programme: osteoarthritis therapy - Canadian Arthritis Network/GeneNews

Drug Profile

Research programme: osteoarthritis therapy - Canadian Arthritis Network/GeneNews

Alternative Names: Osteoarthritis therapy research programme - Canadian Arthritis Network/GeneNews

Latest Information Update: 01 Jun 2007

Price : $50

At a glance

  • Originator Canadian Arthritis Network; GeneNews Limited
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Osteoarthritis

Most Recent Events

  • 01 Jun 2007 Discontinued - Preclinical for Osteoarthritis in Canada (unspecified route)
  • 03 Nov 2006 ChondroGene is now called GeneNews
  • 04 Dec 2003 Preclinical trials in Osteoarthritis in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top